Ignite Creation Date:
2024-05-06 @ 8:07 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06260410
Status:
RECRUITING
Last Update Posted:
2024-04-22
First Post:
2024-02-07
Brief Title:
Data Collection in Lutetium Treated Prostate Cancer Recording of Progression and Tumor Characteristics
Sponsor:
Erasmus Medical Center
Organization:
Erasmus Medical Center
Study Overview
Official Title:
Data Collection in Lutetium Treated Prostate Cancer Recording of Progression and Tumor Characteristics
Status:
RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
LUTRAC
Brief Summary:
This prospective study aims to collect data and blood biomarkers from patients undergoing Lu-PSMA therapy at the Erasmus MC In doing so it will provide real-world efficacy and safety data on the drug gather dosimetry data and explore putative biomarkers to identify patients who most benefit from Lu-PSMA treatment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NL8467207823 | OTHER | CCMO | None |